B02BX09 fostamatinib
ATC group of level 5 – chemical substance · in plain English: medicines to stop bleeding
This site has the patient leaflet or the SPC of 2 medicines in this group.
- 2 prescription only (POM)
Active substance: Fostamatinib – all medicines with this substance, also in combinations.
Place in the ATC classification
- B Blood and blood forming organ drugs 1,013 medicines
- B02 Antihemorrhagics 196 medicines
- B02B Vitamin K and other hemostatics 180 medicines
- B02BX Other systemic hemostatics 28 medicines
- B02BX09 fostamatinib 2 medicines
- B02BX Other systemic hemostatics 28 medicines
- B02B Vitamin K and other hemostatics 180 medicines
- B02 Antihemorrhagics 196 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Tavlesse 100 mg film-coated tablets SPC | Prescription only (POM) |
| Tavlesse 150 mg film-coated tablets SPC | Prescription only (POM) |
Other groups of the same level
- B02BX04 romiplostim 4 medicines
- B02BX05 eltrombopag 16 medicines
- B02BX06 emicizumab 2 medicines
- B02BX07 lusutrombopag 1 medicine
Other names of the ATC group
- German: B02BX09 Fostamatinib
- German: B02BX09 Fostamatinib
- Italian: B02BX09 FOSTAMATINIB
- Turkish: B02BX09 fostamatinib
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group B02BX09
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.